Evaluation of the Stochastic Effects of Low-Dose Radiation: Dose Reconstruction for the Techa River Cohort in Russia

摘要

Persons traveling in space can accumulate fairly large doses of radiation, up to several Sv, at low-to-moderate dose rates. In general these dose rates are low enough so that deterministic effects can be avoided, although shielding may be necessary. An important question, however, is the stochastic effects (induction of cancer and genetic defects) of these doses. Most radiation-risk estimates are based on dose reconstruction and epidemiologic follow-up of the survivors of the atomic bombings on Japan, events that delivered doses nearly instantaneously. It has been hoped that stochastic effects would be less probable for radiation delivered at lower dose rates, but few opportunities have been available to examine this question in humans. The Mayak Production Association (MPA) was the first Russian site for the production and separation of plutonium. This plant began operation in 1948, and during its early days there were high occupational doses as well as technological failures that resulted in the release of large amounts of waste (about 10 (up arrow) 17 Bq of liquid wastes) into the rather small Techa River. Residents along the Techa River were exposed to external radiation, and they ingested foods contaminated with 90Sr and other radionuclides. The Techa River Cohort has been studied for several years by scientists from the Urals Research Center for Radiation Medicine (URCRM). The purpose of the project considered here is to improve the dose-reconstruction system for the Techa River Cohort that has been under development for many years by Russian scientists at the URCRM. This, and the companion epidemiologic studies, are deemed to be unique and important, as members of the Techa River Cohort received red bone marrow doses of up to 3 Gy, but at low-to-moderate-dose rates. An increase in leukemia and cancer mortality has already been noted for this population, and further study should allow the evaluation of dose-rate-reduction factors for this situation.